231 related articles for article (PubMed ID: 28853202)
1. Ursodeoxycholic acid: Effects on hepatic unfolded protein response, apoptosis and oxidative stress in morbidly obese patients.
Mueller M; Castro RE; Thorell A; Marschall HU; Auer N; Herac M; Rodrigues CMP; Trauner M
Liver Int; 2018 Mar; 38(3):523-531. PubMed ID: 28853202
[TBL] [Abstract][Full Text] [Related]
2. miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease.
Castro RE; Ferreira DM; Afonso MB; Borralho PM; Machado MV; Cortez-Pinto H; Rodrigues CM
J Hepatol; 2013 Jan; 58(1):119-25. PubMed ID: 22902550
[TBL] [Abstract][Full Text] [Related]
3. Ursodeoxycholic Acid (UDCA) Exerts Anti-Atherogenic Effects by Inhibiting Endoplasmic Reticulum (ER) Stress Induced by Disturbed Flow.
Chung J; Kim KH; Lee SC; An SH; Kwon K
Mol Cells; 2015 Oct; 38(10):851-8. PubMed ID: 26442866
[TBL] [Abstract][Full Text] [Related]
4. Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity.
Mueller M; Thorell A; Claudel T; Jha P; Koefeler H; Lackner C; Hoesel B; Fauler G; Stojakovic T; Einarsson C; Marschall HU; Trauner M
J Hepatol; 2015 Jun; 62(6):1398-404. PubMed ID: 25617503
[TBL] [Abstract][Full Text] [Related]
5. Ursodeoxycholic acid alleviates nonalcoholic fatty liver disease by inhibiting apoptosis and improving autophagy via activating AMPK.
Wu P; Zhao J; Guo Y; Yu Y; Wu X; Xiao H
Biochem Biophys Res Commun; 2020 Aug; 529(3):834-838. PubMed ID: 32595039
[TBL] [Abstract][Full Text] [Related]
6. Tunicamycin-Induced ER Stress is Accompanied with Oxidative Stress via Abrogation of Sulfur Amino Acids Metabolism in the Liver.
Kim SH; Kwon DY; Kwak JH; Lee S; Lee YH; Yun J; Son TG; Jung YS
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30567393
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic effects of curcumin and ursodexycholic acid on non-alcoholic fatty liver disease.
Gheibi S; Gouvarchin Ghaleh HE; Motlagh BM; Azarbayjani AF; Zarei L
Biomed Pharmacother; 2019 Jul; 115():108938. PubMed ID: 31071511
[TBL] [Abstract][Full Text] [Related]
8. Ursodeoxycholic acid ameliorates hepatic lipid metabolism in LO2 cells by regulating the AKT/mTOR/SREBP-1 signaling pathway.
Hu J; Hong W; Yao KN; Zhu XH; Chen ZY; Ye L
World J Gastroenterol; 2019 Mar; 25(12):1492-1501. PubMed ID: 30948912
[TBL] [Abstract][Full Text] [Related]
9. The 78-kD Glucose-Regulated Protein Regulates Endoplasmic Reticulum Homeostasis and Distal Epithelial Cell Survival during Lung Development.
Flodby P; Li C; Liu Y; Wang H; Marconett CN; Laird-Offringa IA; Minoo P; Lee AS; Zhou B
Am J Respir Cell Mol Biol; 2016 Jul; 55(1):135-49. PubMed ID: 26816051
[TBL] [Abstract][Full Text] [Related]
10. Bicyclol attenuates tetracycline-induced fatty liver associated with inhibition of hepatic ER stress and apoptosis in mice.
Yao XM; Li Y; Li HW; Cheng XY; Lin AB; Qu JG
Can J Physiol Pharmacol; 2016 Jan; 94(1):1-8. PubMed ID: 26640164
[TBL] [Abstract][Full Text] [Related]
11. Omega-3 Polyunsaturated Fatty Acid: A Pharmaco-Nutraceutical Approach to Improve the Responsiveness to Ursodeoxycholic Acid.
Thérien A; Cieślak A; Verreault M; Perreault M; Trottier J; Gobeil S; Vohl MC; Barbier O
Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444777
[TBL] [Abstract][Full Text] [Related]
12. Ipragliflozin Ameliorates Endoplasmic Reticulum Stress and Apoptosis through Preventing Ectopic Lipid Deposition in Renal Tubules.
Hosokawa K; Takata T; Sugihara T; Matono T; Koda M; Kanda T; Taniguchi S; Ida A; Mae Y; Yamamoto M; Iyama T; Fukuda S; Isomoto H
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31888083
[TBL] [Abstract][Full Text] [Related]
13. Ursodeoxycholic acid improves insulin sensitivity and hepatic steatosis by inducing the excretion of hepatic lipids in high-fat diet-fed KK-Ay mice.
Tsuchida T; Shiraishi M; Ohta T; Sakai K; Ishii S
Metabolism; 2012 Jul; 61(7):944-53. PubMed ID: 22154323
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress mediated Ca(2+) release manifests endoplasmic reticulum stress leading to unfolded protein response in UV-B irradiated human skin cells.
Farrukh MR; Nissar UA; Afnan Q; Rafiq RA; Sharma L; Amin S; Kaiser P; Sharma PR; Tasduq SA
J Dermatol Sci; 2014 Jul; 75(1):24-35. PubMed ID: 24794973
[TBL] [Abstract][Full Text] [Related]
15. Fenofibrate treatment attenuated chronic endoplasmic reticulum stress in the liver of nonalcoholic fatty liver disease mice.
Zhang N; Lu Y; Shen X; Bao Y; Cheng J; Chen L; Li B; Zhang Q
Pharmacology; 2015; 95(3-4):173-80. PubMed ID: 25896720
[TBL] [Abstract][Full Text] [Related]
16. Omega-3 polyunsaturated fatty acid and ursodeoxycholic acid have an additive effect in attenuating diet-induced nonalcoholic steatohepatitis in mice.
Kim JK; Lee KS; Lee DK; Lee SY; Chang HY; Choi J; Lee JI
Exp Mol Med; 2014 Dec; 46(12):e127. PubMed ID: 25523099
[TBL] [Abstract][Full Text] [Related]
17. Enhanced endoplasmic reticulum SERCA activity by overexpression of hepatic stimulator substance gene prevents hepatic cells from ER stress-induced apoptosis.
Zhang J; Li Y; Jiang S; Yu H; An W
Am J Physiol Cell Physiol; 2014 Feb; 306(3):C279-90. PubMed ID: 24284796
[TBL] [Abstract][Full Text] [Related]
18. Attenuated lipotoxicity and apoptosis is linked to exogenous and endogenous augmenter of liver regeneration by different pathways.
Weiss TS; Lupke M; Ibrahim S; Buechler C; Lorenz J; Ruemmele P; Hofmann U; Melter M; Dayoub R
PLoS One; 2017; 12(9):e0184282. PubMed ID: 28877220
[TBL] [Abstract][Full Text] [Related]
19. Ursodeoxycholic acid as a means of preventing atherosclerosis, steatosis and liver fibrosis in patients with nonalcoholic fatty liver disease.
Nadinskaia M; Maevskaya M; Ivashkin V; Kodzoeva K; Pirogova I; Chesnokov E; Nersesov A; Kaibullayeva J; Konysbekova A; Raissova A; Khamrabaeva F; Zueva E
World J Gastroenterol; 2021 Mar; 27(10):959-975. PubMed ID: 33776366
[TBL] [Abstract][Full Text] [Related]
20. Modulation of the Unfolded Protein Response by Tauroursodeoxycholic Acid Counteracts Apoptotic Cell Death and Fibrosis in a Mouse Model for Secondary Biliary Liver Fibrosis.
Paridaens A; Raevens S; Devisscher L; Bogaerts E; Verhelst X; Hoorens A; Van Vlierberghe H; van Grunsven LA; Geerts A; Colle I
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
